The disposition of biphenylacetic acid following topical application

Cuisanaud G, Legheand J, Llorca G, Belkahia C, Lejeune E, Sassard J (1979) Pharmacokinetics of fenbufen in man. Eur J Clin Pharmacol 16: 59?61

Furst DE (1985) Synovial fluid kinetics of non steroidal anti-inflammatory drugs. Agents Actions 17 [Suppl]: 65?77

Kewar SS (1983) Pharmacological properties of fenbufen. J Am Med Assoc 250: 84?90

Mizushima Y (1982) Basic and clinical study of produgs of nonsteroidal anti-inflammatory drugs. Pharmacology 25: [Suppl 1]: 39?45

Robinson JR (ed) (1979) Sustained and controlled drug release drug delivery systems. Marcel Dekker. New York

Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA (1959) Revision of diagnostic criteria in rheumatoid arthritis. Ann Rheum Dis 18: 49?53

Sugawara Y, Ono H, Ueda R, Ishigami M, Kubodera T, Fujiwara H, Sato Y, Yamasaki K (1985) Percutaneous absorption and tissue distribution of L-141 topical agent. J Med Pharmacol 13 (in Japanese, translation supplied by Cyanamid Clinical Research International, Pearl River, NY, USA)

Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature N Biol 231: 232?235

Dawson M, McGee CM, Brooks PM, Vine JH, Lacey E, Watson TR (1987) Quantitation of biphenylacetic acid in plasma and synovial fluid by gas chromatography/mass spectrometry/mass spectrometry. J Chromatogr 420: 129?134